Stable Gastric Pentadecapeptide BPC 157 in Rats Subjected to High Fructose (80%) Diet for One Month Counteracts Hypertension and Compromised Optic Disc Head Circulation and Following Atrophy
Now, let's turn to the compound at the center of this discussion: BPC-157
Sources: Sikiric et al., Curr Pharm Des 2018 | Chang et al., J Appl Physiol 2011 Security Profile & Chemical Identity Molecular specifications and preclinical safety data BPC-157 Chemical Identity Synthetic pentadecapeptide derived from human gastric juice BPC-157 Tolerance & Status Safety data from preclinical studies (rat, mouse, rabbit, dog) Published Preclinical Data 6 key studies published in J Orthop Res, J Appl Physiol, Curr Pharm Des, Growth Horm IGF Res and Am J Sports Med Biomechanics Significant improvement in tendon strength, stiffness and elasticity modulus at 14 days Achilles tendon repair (rat) Migration Dose-dependent acceleration of tendon fibroblast migration Tendon Repair Mechanisms Cytoprotection Novel cytoprotective mediator vascular recruitment and healing of the gastrointestinal tract Documented Gastroprotective Effects Important Notice Search Only Not intended for human consumption

This range translates to approximately 1.6 to 4.0 micrograms per kilogram of body weight when scaled from effective animal doses
BPC-157 Administration, Dosage, and Safety Considerations Available Forms and Injection Methods BPC-157 comes as a lyophilized powder for intramuscular, subcutaneous, or intra-articular injections